Back to search
FDAFDA · Food and drugs·Recall number D-0694-2026

TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01.

Published July 8, 2026 · Recall initiated: April 8, 2026

Summary

FDA records drug Class II recall D-0694-2026, published July 8, 2026 and initiated April 8, 2026. Recalling firm: Blaine Labs Inc; Status: Ongoing; Reported quantity: 144 bottles; Lot: Lot #BL3411R, Exp 6/8/2027. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Ongoing — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

What to do

Voluntary: Firm initiated · Press Release

Get an email if TRIPENICOL S has another recall

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Brand
TRIPENICOL S
Manufacturer
Blaine Labs Inc
Distributor
Nationwide in the USA
Lot
Lot #BL3411R, Exp 6/8/2027
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was TRIPENICOL S Antifungal Solution (Undecylenic Acid 25%), 1.25 FL OZ (37.5 mL) bottle, Manufactured For: Trifluent Pharma, LLC, San Antonio, TX 78213, NDC 73352-550-01. recalled?

Yes. FDA published recall D-0694-2026 on July 8, 2026. Reported hazard: CGMP Deviations; the firm discontinued required stability testing for products on the market still within expiry

What should I do if I have this product?

Voluntary: Firm initiated · Press Release

How do I know if my unit is part of the recall?

Compare your product details with the notice. Brand: TRIPENICOL S.